214 related articles for article (PubMed ID: 20639252)
21. Reduction in colorectal cancer mortality related to annual fecal occult blood screening--13 year follow-up of 46,000 subjects.
Kita MW
J Insur Med; 1993; 25(2):138-9. PubMed ID: 10146315
[No Abstract] [Full Text] [Related]
22. Fecal-occult-blood test screening for colorectal cancer.
Zacks M
J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
[No Abstract] [Full Text] [Related]
23. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
Logan RF
Gut; 2008 Sep; 57(9):1333; author reply 1333-4. PubMed ID: 18719146
[No Abstract] [Full Text] [Related]
24. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
25. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
26. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
Saito H
J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
29. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
[TBL] [Abstract][Full Text] [Related]
30. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
31. Centralised faecal blood testing for both screening and pathology requests.
Edwards JB
Pathology; 2010 Dec; 42(7):700-4. PubMed ID: 21080891
[No Abstract] [Full Text] [Related]
32. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
Nash GF
Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
[No Abstract] [Full Text] [Related]
33. Sex differences in performance of fecal occult blood testing.
Brenner H; Haug U; Hundt S
Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
[TBL] [Abstract][Full Text] [Related]
34. [Colorectal cancer screening. Where are we?].
Benhaberou-Brun D
Perspect Infirm; 2013; 10(3):52-5. PubMed ID: 23710531
[No Abstract] [Full Text] [Related]
35. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
36. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
Jansen JB; van Rossum LG; Laheij RJ
Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
[TBL] [Abstract][Full Text] [Related]
37. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology and screening of colorectal cancer].
Dancourt V; Faivre J
Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
[TBL] [Abstract][Full Text] [Related]
40. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
